Lynxiclav Suspension 457mg contains a combination of amoxicillin and clavulanate potassium to treat bacterial infections, especially those resistant to other antibiotics.
Mechanism of Action:
- Amoxicillin interferes with bacterial cell wall synthesis
- Clavulanate potassium enhances amoxicillin’s efficacy against beta-lactamase-producing bacteria
- This dual antibacterial coverage combats infection more effectively
Dosage Guidelines:
- Pediatric dose 30-90 mg/kg/day divided every 12 hours
- Adult dose 250-875 mg every 8-12 hours depending on infection type
- Taken by mouth with or without food
- Liquid form allows easy dosage adjustment across patient ages
- 10-14 days typical treatment duration
Important Safety Info:
- Diarrhea, nausea, and skin rash are common side effects
- Probenecid decreases the renal excretion of Lynxiclav Suspension
- May cause false positive urine protein tests
- Yeast overgrowth and antibiotic-associated colitis are possible
- Refrigerated suspension retains potency for 10 days
With the synergistic combination, Lynxiclav Suspension combats infections unresponsive to singular antibiotics when appropriately dosed. Follow all instructions from the prescribing physician.
Reviews
There are no reviews yet.